Addex Therapeutics Ltd. (fka ADDXF)

[tykundegex]

Addex changes name to Addex Therapeutics

http://www.addextherapeutics.com/investors/press-releases/news-details/article/addex-changes-name-to-addex-therapeutics/

Addex Pharmaceuticals (SIX:ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that it has changed its name to Addex Therapeutics. The name change reflects more closely the company’s focus on oral small molecule-based therapeutics. Addex’s ticker symbol on the Swiss Stock Exchange remains unchanged at ADXN.

Alongside the name change, Addex has revealed a new logo and website. The icon in the logo represents two things: the letter “X” from the Addex name and a receptor bound by a natural ligand or cell signaling molecule in the active site, depicted in blue, and an allosteric modulator bound to an allosteric site, in orange.

Addex has also introduced a new tag line: “expanding the realm of possible…” which is literally what the allosteric approach is doing for drug discovery. When applied to drug discovery, allostery offers the unique possibility of developing oral small molecule drugs for targets that were previously considered “undruggable” with conventional drug discovery approaches. Addex technology, therefore, expands the realm of druggable targets.

The new website provides information on the company’s strategy, pipeline and the allosteric modulation-based drug discovery and development technology platform. The new website also provides helpful information on the stock, corporate governance and corporate calendar featuring the company’s investor, media and scientific outreach activities.